Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Obesity With Diabetes, Overweight With Diabetes
In brief
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on: * Percent change in body weight * Change in hemoglobin A1c (HbA1c)
Key facts
- Study ID
- NCT07284901
- Run by
- Kailera
- People needed
- 1156
- Starts
- 2026-01-12
- Expected to finish
- 2028-04-24
- Last updated by the study team
- 2026-07-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kailera Clinical Site — Cullman, Alabama, United States (enrolling)
- Kailera Clinical Site — Sun City, Arizona, United States (enrolling)
- Kailera Clinical Site — Phoenix, Arizona, United States (enrolling)
- Kailera Clinical Site — Escondido, California, United States (enrolling)
- Kailera Clinical Site — Montclair, California, United States (enrolling)
- Kailera Clinical Site — Northridge, California, United States (enrolling)
- Kailera Clinical Site — Oceanside, California, United States (enrolling)
- Kailera Clinical Site — Little Rock, Arkansas, United States (enrolling)
- Kailera Clinical Site — Stamford, Connecticut, United States (enrolling)
- Kailera Clinical Site — Jupiter, Florida, United States (enrolling)
- Kailera Clinical Site — Miami, Florida, United States (enrolling)
- Kailera Clinical Site — Orange City, Florida, United States (enrolling)
- Kailera Clinical Site — Orlando, Florida, United States (enrolling)
- Kailera Clinical Site — Orlando, Florida, United States (enrolling)
- Kailera Clinical Site — The Villages, Florida, United States (enrolling)
- Kailera Clinical Site — Lilburn, Georgia, United States (enrolling)
- Kailera Clinical Site — Skokie, Illinois, United States (enrolling)
- Kailera Clinical Site — Toluca Lake, California, United States (enrolling)
- Kailera Clinical Site — Newton, Kansas, United States (enrolling)
- Kailera Clinical Site — Shreveport, Louisiana, United States (enrolling)
- Kailera Clinical Site — Columbia, Maryland, United States (enrolling)
- Kailera Clinical Site — Farmington Hills, Michigan, United States (enrolling)
- Kailera Clinical Site — Missoula, Montana, United States (enrolling)
- Kailera Clinical Site — Lincoln, Nebraska, United States (enrolling)
- Kailera Clinical Site — Las Vegas, Nevada, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.